Correlation of 111In-Ibritumomab Pretherapy Scans and Outcomes of 90Y-Ibritumomab Therapy in Studied Population
| Pretherapy scan findings | ||
|---|---|---|
| Outcome | Positive | Negative |
| Complete response (9/28) | 2 | 7 |
| Partial response (8/28) | 7 | 1 |
| Mixed response (4/28) | 4 | 0 |
| No change (4/28) | 3 | 1 |
| Progressive disease (3/28) | 3 | 0 |
Data are numbers of patients with positive or negative 111In-ibritumomab findings before therapy.